General Information of Drug (ID: DM1X1QZ)

Drug Name
18F-fluorothymidine
Synonyms 3'-Deoxy-3'-[18F]fluorothymidine; AC1L9P5W; SCHEMBL10017180; MOLI001306; NSC743144; NSC-743144; radiolabeled form of 3'-deoxy-3'-fluorothymidine (FLT) (NSC 140025)
Indication
Disease Entry ICD 11 Status REF
Breast cancer 2C60-2C65 Phase 2 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C10H13FN2O4
Canonical SMILES
CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)F
InChI
1S/C10H13FN2O4/c1-5-3-13(10(16)12-9(5)15)8-2-6(11)7(4-14)17-8/h3,6-8,14H,2,4H2,1H3,(H,12,15,16)/i11-1
InChIKey
UXCAQJAQSWSNPQ-KXMUYVCJSA-N
Cross-matching ID
PubChem CID
450772
TTD ID
D0A1RP

References

1 ClinicalTrials.gov (NCT00572728) 3'-Deoxy-3'-18F Fluorothymidine PET/CT in Predicting Response To Chemotherapy Before Surgery in Patients With Locally Advanced Breast Cancer. U.S. National Institutesof Health.